According to the National Cancer Institute (NCI) , 56 percent of lung and bronchus cancer cases are diagnosed at stage 4. If this statistic does not increase screening for non-smokers, I don't know what will. Absolutely unacceptable and undebatable to exclude non smokers.

An AI system about to be trialled in NHS hospitals should halve the time it takes to get a lung cancer diagnosis, The i Paper has revealed. inews.co.uk/news/science/n…

Qure.ai partners AstraZeneca, leveraging our #AI chest X-ray solution, #qXR, for early detection of #LungCancer. #qXR has been deployed in 13 countries, helping improve patient outcomes across Latin America, Asia, the Middle East, and Africa. Read here bit.ly/3pv0Fw8

📢Delighted to partner AstraZeneca & PATH to use innovative #technology for a transformative framework for early diagnosis of #lungcancer & other pulmonary diseases, leveraging current #tuberculosis screening procedures. Critical for making Universal Lung health a reality

Good luck to all the 4th year med students learning today whether they matched. Remember, too, that at least a couple of the most admirable docs I know didn't match on the first try, and that's OK -- we're here for you. ❤️ #Match2022

Congrats to all those finding out they've matched into neurosurgery! And best of luck to those putting together their SOAP lists #Match2022 #neurosurgery #nsgymatch

At HIMSS this week? Qure.ai's Mazin Jaliwala is there to discuss how our clients use #AI to help their radiology practice manage complex worklists, prioritize scans & improve patient outcomes. DM me if you'd like me to connect you.

Study led by Raymond Osarogiagbon, MBBS, FACP at Baptist Health Cancer Center highlights the need for incidental detection of lung nodules. USPSTF #LDCT guidelines are a great start but only a start. #lungcancer Qure.ai ascopubs.org/doi/10.1200/JC…

#PLCC22 Insightful conversation with Terri Ann DiJulio and Dr. Lecia Sequist, MD, MPH, FASCO on early detection and the stigma of lung cancer. Lung cancer often not considered in younger patients, leading to costly delays, and when the first question is "Did you smoke" - it feels accusatory.

Lung-RADS continues to evolve and v2.0 will arrive soon this summer. American College of Radiology Lung-RADS Committee Chair Jared Christensen MD, MBA from Duke Radiology discusses several upcoming changes re: atypical pulmonary cysts, endobronchial nodules & stepped management at #STR2022. #lungcancerscreening

I'm with LTE Medical Solutions at the #TB screening camp taking place in #BarklyWest, 🇿🇦 for #WorldTuberculosisDay. Great to see the mobile truck with CXR setup using Qure.ai's #AI solution qTrack to screen the community for TB.

📢#FundingAlert Delighted to secure investment that will extend & strengthen our global reach and intensify product development for critical care & community diagnostics. See all details at: bit.ly/3IPje51 Novo Holdings Healthquad MassMutual Ventures

LDCT lung cancer screenings are more common among those least-likely to benefit, according to this study in JAMA Oncology by @AlisonRustagi Amy L. Byers & Salomeh Keyhani, MD, MPH jamanetwork.com/journals/jaman…

I need to create more simple experiments like these! 🧪 Why do we need elastic arteries?! 🫀 Systolic vs Diastolic 🩸 #MedEd #MedTwitter #FOAMed #CardioTwitter

One of the most promising applications of AI, is in potential time-savings, effected by segregation of normals and abnormals (with inbuilt safety checks) Has the potential to - Free up time for critical findings on abnormal scans - act as a background reader for backup & More...

Qure.ai venturing into places to bring #diagnosis where no one else has. #everest #everestbasecamp #Himalayas #Nepal #ebc2022 #ArtificialIntelligence #MachineLearning #lunghealth

Thank you for your support @SamridhHealth !

Beautiful hospital + scenery in Nepal - Qure.ai Penn Radiology MinXray, Inc. + local physicians have partnered to bring AI-assisted imaging to remote villages in the country.

🚨 Team Qure.ai (Prashant Warier, Dara Kelleher, Sahil Chanchad) has successfully deployed qXR - our Chest X-ray screening tool, at 🏔️Everest Base Camp (alt. 5364m). Many thanks to Saurabh Jha of Penn Radiology & MinXray, Inc.'s Mike Cairnie for being integral to this landmark expedition

The survival rate for lung cancer does NOT need to be this low! Catching it at an early stage as Dr. Nipun J. from our parters AstraZeneca shares, Artificial intelligence can have a tremendous impact on survival rates and outcomes for patients. Qure.ai